Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand
ACS Chemical Neuroscience · 2024
DOI: 10.1021/acschemneuro.4c00493 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Dinahlee Saturnino Guarino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Positron-Emission Tomography, alpha-Synuclein, Macaca fascicularis, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Hj?rnfonden, Parkinson Fonden.
Abstract (Originalsprache)
The accumulation of aggregated α-synuclein (α-syn) is a pathological hallmark of Parkinson's disease (PD) and other synucleinopathies. Here within, we report the in vitro characterization targeting site 2 of α-syn fibrils and in vivo evaluation of NHPs of KAC-50.1 as a potential α-syn positron emission tomography (PET) radioligand. Preclinical studies were performed using a multidimensional approach of post-mortem brain imaging techniques, radioligand binding, and biochemical studies. These experiments were followed by PET imaging in cynomolgus monkeys using [11C]KAC-50.1. [3H]KAC-50.1 displayed a KD of 35 nM toward site 2 in recombinant α-syn fibrils. Specific binding of [3H]KAC-50.1 was observed in brain tissues with abundant α-syn pathology but also in AD, PSP, and CBD cases, indicating binding to amyloid β (Aβ) and tau pathology. PET studies showed a rapid entrance of [11C]KAC-50.1 into the brain and relatively rapid washout from cortical brain regions, with slower washout in subcortical regions. [3H]KAC-50.1 is a ligand that binds to fibrillar α-syn but shows limited selectivity for α-syn versus Aβ and tau fibrils. PET studies in NHPs indicate that [11C]KAC-50.1, despite reversible kinetic properties, displays retention in white matter. Altogether, the in vitro and in vivo properties do not support further development of [11C]KAC-50.1 as a PET imaging agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, BioClinicum, Floor 4, Akademiska Stråket 1, 17174 Solna, Sweden.
- Offspring Biosciences, Sweden AB, SE-151 36 Södertälje, Sweden.
- Applied Immunology, Department of Clinical Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden.
- Isotope Chemistry, Drug Safety and Metabolism, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.
- AlzeCure Pharma AB, Hälsovägen 7, SE-141 57 Huddinge, Sweden.
ORCID-Profile: Dinahlee Saturnino Guarino, Charles S Elmore, Miguel Cortes-Gonzalez, Robert H Mach, Magnus Schou
Förderung
- Michael J. Fox Foundation for Parkinson's Research
- Hj?rnfonden
- Parkinson Fonden
Zitieren
APA
Saturnino Guarino, D., Miranda Azpiazu, P., Sunnemark, D., Elmore, C. S., Bergare, J., Artelsmair, M., Nordvall, G., Forsberg Morén, A., Jia, Z., Cortes-Gonzalez, M., Mach, R. H., Wilcox, K. C., Finnema, S., Schou, M., & Varrone, A. (2024). Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00493
Vancouver
Saturnino Guarino D, Miranda Azpiazu P, Sunnemark D, Elmore CS, Bergare J, Artelsmair M, et al. Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00493
BibTeX
@article{SaturninoGuarino2024,
author = {Saturnino Guarino, Dinahlee and Miranda Azpiazu, Patricia and Sunnemark, Dan and Elmore, Charles S and Bergare, Jonas and Artelsmair, Markus and Nordvall, Gunnar and Forsberg Morén, Anton and Jia, Zhisheng and Cortes-Gonzalez, Miguel and Mach, Robert H and Wilcox, Kyle C and Finnema, Sjoerd and Schou, Magnus and Varrone, Andrea},
title = {Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand},
journal = {ACS Chemical Neuroscience},
year = {2024},
doi = {10.1021/acschemneuro.4c00493}
}
EUVIMED